See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.64▲ 1.74%
← PAMPALO page
XStocksXray
Market X-Ray report · 27 October 2026

Endomines Finland Oyj (PAMPALO)

Nasdaq Helsinki · Finland · prices in EUR · close of 27 Oct 2026

Key indicators

Last closeEUR 7.900
52-week range7.210 – 12.300
Return, 1 month / 3 months−21.2% / +2.5%
Return, 1 year / 3 years−12.9% / +645.3%
TrendBelow its 200-day average
RSI (14)27
Volatility (1 year)47.4%
Worst drawdown (1 year)-38.4%
Average daily value traded0.46M EUR
Dividend yield–

Market X-Ray price-based

44/ 100 · High confidence · ahead of 38% of stocks on this exchange
Trend38
Momentum49
Stability (higher is calmer)25
Liquidity76
Income–

Five-year price chart navy: price · brown: 200-day average

0.373.586.789.9813.192021-102023-012024-042025-072026-10

About the company

Endomines Finland Oyj is a mining company that explores for and produces gold. Its main operation is the Pampalo gold mine in eastern Finland, where it mines and processes ore to produce gold concentrate. The company also carries out exploration work at other gold properties in Finland and in the United States. It is based in Finland and serves the gold market through the concentrate it produces.

The shares are listed on the Nasdaq Helsinki in Finland under the code PAMPALO, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Endomines Finland Oyj (PAMPALO) trades on the Nasdaq Helsinki in Finland. It last closed at EUR 7.900 on 27 October 2026.

Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 119 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 12.9% and over the last three months it rose 2.5%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Endomines Finland Oyj (PAMPALO)

The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Helsinki

Lens and metricValueScoreReading
Trend38 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-15.3%
From 52-week high-33.0%
Momentum49 · WeakLagging most stocks on this exchange.
3-month return2.5%
6-month return-17.4%
12-month return, skipping the last month10.5%
Stability (higher is calmer)25 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)47.4%
Worst drawdown, 1 year (smaller is calmer)-38.4%
Liquidity76 · StrongTrades actively.
Average daily value traded0.46M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−10.0%
1 month−21.2%
3 months+2.5%
6 months−17.4%
1 year−12.9%
3 years+645.3%
5 years+115.5%

Signals

50-day / 200-day average9.495 / 9.328
Golden / death cross (60 days)Golden, 14 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.363

Technical summary

DailyBearish4 bullish · 0 neutral · 12 bearish
WeeklyBearish3 bullish · 1 neutral · 8 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Helsinki; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026